<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/32319/pv-reporter-interviews-dr-jean-jacques-kiladjian-at-ash-2017?channelName=PVReporter&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

PV Reporter Interviews Dr. Jean Jacques Kiladjian at ASH ...

Name: PV Reporter Interviews Dr. Jean Jacques Kiladjian at ASH ...
Uploaded: 2018-01-02T10:30:21
Duration: 8 min 54 s
Description: Ropeginterferon Alfa-2b Induces High Rates of Clinical, Hematological and Molecular Responses in PV Patients. Two - year results from the First Prospective Randomized Controlled Trial

PV Reporter Interviews Dr. Jean Jacques Kiladjian at ASH 2017

00:08:54

David

5 years 473 Views

Share Add to Report 0 0

Embed (Iframe):

<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/32319/pv-reporter-interviews-dr-jean-jacques-kiladjian-at-ash-2017?channelName=PVReporter&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Embed (Object):

<div class="embed-responsive embed-responsive-16by9"><object width="640" height="360"><param name="movie" value="https://oncologytube.com/videoEmbed/32319/pv-reporter-interviews-dr-jean-jacques-kiladjian-at-ash-2017?channelName=PVReporter&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit="></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="https://oncologytube.com/videoEmbed/32319/pv-reporter-interviews-dr-jean-jacques-kiladjian-at-ash-2017?channelName=PVReporter&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" allowscriptaccess="always" allowfullscreen="true" width="640" height="360"></embed></object></div>

Link (HTML):

<a href="https://oncologytube.com/v/32319?channelName=PVReporter"><img src="https://oncologytubecom.cdn.ypt.me/videos/10002784_oncologytube/10002784_oncologytube.jpg?cache=15669183921678829611">PV Reporter Interviews Dr. Jean Jacques Kiladjian at ASH 2017</a>

Link (BBCode):

[url=https://oncologytube.com/v/32319?channelName=PVReporter][img]https://oncologytubecom.cdn.ypt.me/videos/10002784_oncologytube/10002784_oncologytube.jpg?cache=15669183921678829611[/img]PV Reporter Interviews Dr. Jean Jacques Kiladjian at ASH 2017[/url]

Sign in now!

Permanent Link

URL Friendly (SEO)

Current Time (SEO)

Category:

Acute Lymphoblastic Leukemia

Description:

Ropeginterferon Alfa-2b Induces High Rates of Clinical, Hematological and Molecular Responses in PV Patients. Two - year results from the First Prospective Randomized Controlled Trial